Radiotherapy combined with ICRF 159 (NSC 129943)

Antitumour Activity in a Series of bisDiketopiperazines

1969 • 159 citations

Metastases and the Normalization of Tumour Blood Vessels by ICRF 159: A New Type of Drug Action

1972 • 136 citations

Fibrosarcoma of the soft tissues.A clinicopathologic study

1965 • 94 citations

Mode of Action of the Cytostatic Agent ‘ICRF 159’

1970 • 90 citations

The place of radiotherapy in the management of fibrosarcoma of the soft tissues

1966 • 77 citations

Soft tissue sarcoma.A review of 200 cases

1963 • 72 citations

Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.

1974 • 68 citations

Radiation therapy in the palliative management of soft tissue sarcomas

1962 • 65 citations

ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; Razoxane

1976 • 56 citations

Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors

1974 • 48 citations

Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159

1974 • 37 citations

Clinical use of radiation sensitizing agents

1974 • 23 citations

Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159

1974 • 10 citations